LG Chem first acquires commercialization approval of ‘etanercept’ biosimilar in Japan

LG Chem will enter the antibody biopharmaceutical market.

LG Chem announced ‘LBEC0101(Project Name),’ a biosimilar referencing ‘etanercept(original product name: Enbrel)’ for the treatment of rheumatoid arthritis, has acquired commercialization approval from the Japanese Ministry of Health, Labour and Welfare on the 19^th. ‘LBEC0101’ is the only medicine which acquire approval as an ‘etanercept...